Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

From Petri Dishes to Organ on Chip Platform: The Increasing Importance of Machine Learning and Image Analysis.

Mencattini A, Mattei F, Schiavoni G, Gerardino A, Businaro L, Di Natale C, Martinelli E.

Front Pharmacol. 2019 Feb 26;10:100. doi: 10.3389/fphar.2019.00100. eCollection 2019.

2.

The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity.

Afferni C, Buccione C, Andreone S, Galdiero MR, Varricchi G, Marone G, Mattei F, Schiavoni G.

Front Immunol. 2018 Nov 13;9:2601. doi: 10.3389/fimmu.2018.02601. eCollection 2018. Review.

3.

High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.

Tiacci E, Venanzi A, Ascani S, Marra A, Cardinali V, Martino G, Codoni V, Schiavoni G, Martelli MP, Falini B.

N Engl J Med. 2018 Sep 6;379(10):981-984. doi: 10.1056/NEJMc1806413. No abstract available.

PMID:
30184450
4.

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.

Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A, Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, Falini B.

Blood. 2018 May 31;131(22):2454-2465. doi: 10.1182/blood-2017-11-814913. Epub 2018 Apr 12.

5.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Castiello L, Sestili P, Schiavoni G, Dattilo R, Monque DM, Ciaffoni F, Iezzi M, Lamolinara A, Sistigu A, Moschella F, Pacca AM, Macchia D, Ferrantini M, Zeuner A, Biffoni M, Proietti E, Belardelli F, Aricò E.

Cancer Immunol Res. 2018 Jun;6(6):658-670. doi: 10.1158/2326-6066.CIR-17-0675. Epub 2018 Apr 5.

6.

Eosinophils: The unsung heroes in cancer?

Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, Marone G, Schiavoni G.

Oncoimmunology. 2017 Nov 13;7(2):e1393134. doi: 10.1080/2162402X.2017.1393134. eCollection 2018. Review.

7.

Organs on chip approach: a tool to evaluate cancer -immune cells interactions.

Biselli E, Agliari E, Barra A, Bertani FR, Gerardino A, De Ninno A, Mencattini A, Di Giuseppe D, Mattei F, Schiavoni G, Lucarini V, Vacchelli E, Kroemer G, Di Natale C, Martinelli E, Businaro L.

Sci Rep. 2017 Oct 6;7(1):12737. doi: 10.1038/s41598-017-13070-3.

8.

IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.

Lucarini V, Ziccheddu G, Macchia I, La Sorsa V, Peschiaroli F, Buccione C, Sistigu A, Sanchez M, Andreone S, D'Urso MT, Spada M, Macchia D, Afferni C, Mattei F, Schiavoni G.

Oncoimmunology. 2017 Apr 20;6(6):e1317420. doi: 10.1080/2162402X.2017.1317420. eCollection 2017.

9.

Genomics of Hairy Cell Leukemia.

Tiacci E, Pettirossi V, Schiavoni G, Falini B.

J Clin Oncol. 2017 Mar 20;35(9):1002-1010. doi: 10.1200/JCO.2016.71.1556. Epub 2017 Feb 13. Review.

10.

The dangerous liaison between pollens and pollution in respiratory allergy.

Schiavoni G, D'Amato G, Afferni C.

Ann Allergy Asthma Immunol. 2017 Mar;118(3):269-275. doi: 10.1016/j.anai.2016.12.019. Epub 2017 Jan 29. Review.

PMID:
28143681
11.

Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin.

Brunetti L, Di Battista V, Venanzi A, Schiavoni G, Martelli MP, Ascani S, Mecucci C, Tiacci E, Falini B.

Leukemia. 2017 May;31(5):1238-1240. doi: 10.1038/leu.2017.38. Epub 2017 Jan 23. No abstract available.

PMID:
28111467
12.

Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.

Lucarini V, Buccione C, Ziccheddu G, Peschiaroli F, Sestili P, Puglisi R, Mattia G, Zanetti C, Parolini I, Bracci L, Macchia I, Rossi A, D'Urso MT, Macchia D, Spada M, De Ninno A, Gerardino A, Mozetic P, Trombetta M, Rainer A, Businaro L, Schiavoni G, Mattei F.

J Invest Dermatol. 2017 Jan;137(1):159-169. doi: 10.1016/j.jid.2016.08.024. Epub 2016 Sep 10.

13.

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.

Aricò E, Sestili P, Carpinelli G, Canese R, Cecchetti S, Schiavoni G, D'Urso MT, Belardelli F, Proietti E.

Oncotarget. 2016 Sep 13;7(37):59754-59765. doi: 10.18632/oncotarget.10880.

14.

Chlamydia pneumoniae Clinical Isolate from Gingival Crevicular Fluid: A Potential Atherogenic Strain.

Filardo S, Di Pietro M, Schiavoni G, Minniti G, Ortolani E, Romano S, Sessa R.

Front Cell Infect Microbiol. 2015 Nov 25;5:86. doi: 10.3389/fcimb.2015.00086. eCollection 2015.

15.

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, Gerardino A, Manic G, Ulas T, Günther P, Schultze JL, Kepp O, Stoll G, Lefebvre C, Mulot C, Castoldi F, Rusakiewicz S, Ladoire S, Apetoh L, Bravo-San Pedro JM, Lucattelli M, Delarasse C, Boige V, Ducreux M, Delaloge S, Borg C, André F, Schiavoni G, Vitale I, Laurent-Puig P, Mattei F, Zitvogel L, Kroemer G.

Science. 2015 Nov 20;350(6263):972-8. doi: 10.1126/science.aad0779. Epub 2015 Oct 29.

16.

Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.

Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R.

Mediators Inflamm. 2015;2015:378658. doi: 10.1155/2015/378658. Epub 2015 Aug 9. Review.

17.

Frequency domain optical coherence tomography to assess non-ostial left main coronary artery.

Burzotta F, Dato I, Trani C, Pirozzolo G, De Maria GL, Porto I, Niccoli G, Leone AM, Schiavoni G, Crea F.

EuroIntervention. 2015 Jan;10(9):e1-8. doi: 10.4244/EIJV10I9A179.

18.

BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.

Pettirossi V, Santi A, Imperi E, Russo G, Pucciarini A, Bigerna B, Schiavoni G, Fortini E, Spanhol-Rosseto A, Sportoletti P, Mannucci R, Martelli MP, Klein-Hitpass L, Falini B, Tiacci E.

Blood. 2015 Feb 19;125(8):1207-16. doi: 10.1182/blood-2014-10-603100. Epub 2014 Dec 5.

19.

Cancer-driven dynamics of immune cells in a microfluidic environment.

Agliari E, Biselli E, De Ninno A, Schiavoni G, Gabriele L, Gerardino A, Mattei F, Barra A, Businaro L.

Sci Rep. 2014 Oct 16;4:6639. doi: 10.1038/srep06639.

20.

Effects of vaginal lactobacilli in Chlamydia trachomatis infection.

Mastromarino P, Di Pietro M, Schiavoni G, Nardis C, Gentile M, Sessa R.

Int J Med Microbiol. 2014 Jul;304(5-6):654-61. doi: 10.1016/j.ijmm.2014.04.006. Epub 2014 Apr 28.

PMID:
24875405
21.

A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells.

Mattei F, Schiavoni G, De Ninno A, Lucarini V, Sestili P, Sistigu A, Fragale A, Sanchez M, Spada M, Gerardino A, Belardelli F, Businaro L, Gabriele L.

J Immunotoxicol. 2014 Oct;11(4):337-46. doi: 10.3109/1547691X.2014.891677. Epub 2014 Mar 6.

PMID:
24597645
22.

Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting.

Trani C, Porto I, Burzotta F, De Maria GL, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Bolognese L, Schiavoni G, Crea F.

Int J Cardiol. 2014;172(1):e127-9. doi: 10.1016/j.ijcard.2013.12.113. Epub 2014 Jan 5. No abstract available.

PMID:
24462144
23.

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response.

Schiavoni G, Mattei F, Gabriele L.

Front Immunol. 2013 Dec 25;4:483. doi: 10.3389/fimmu.2013.00483. Review.

24.

The dual role of IRF8 in cancer immunosurveillance.

Schiavoni G, Gabriele L, Mattei F.

Oncoimmunology. 2013 Aug 1;2(8):e25476. Epub 2013 Jul 1.

25.

Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress.

Guarino MP, Sessa R, Altomare A, Cocca S, Di Pietro M, Carotti S, Schiavoni G, Alloni R, Emerenziani S, Morini S, Severi C, Cicala M.

Dig Liver Dis. 2013 Dec;45(12):1011-6. doi: 10.1016/j.dld.2013.06.001. Epub 2013 Jul 26.

PMID:
23891549
26.

Resveratrol in Chlamydia pneumoniae-induced foam cell formation and interleukin-17A synthesis.

Di Pietro M, De Santis F, Schiavoni G, Filardo S, Sessa R.

J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):509-18.

PMID:
23830400
27.

Impact of operator experience and wiring technique on procedural efficacy of trans-radial percutaneous chronic total occlusion recanalization performed by dedicated radialists.

Burzotta F, Trani C, Tommasino A, Brancati MF, Saffioti S, Pirozzolo G, Niccoli G, Leone AM, Schiavoni G, Crea F.

Cardiol J. 2013;20(5):560-7. doi: 10.5603/CJ.a2013.0063. Epub 2013 Jun 25.

28.

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.

Bracci L, Schiavoni G, Sistigu A, Belardelli F.

Cell Death Differ. 2014 Jan;21(1):15-25. doi: 10.1038/cdd.2013.67. Epub 2013 Jun 21. Review.

29.

Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.

Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, Fernandez C, Singh M, Gabriele L.

Eur J Immunol. 2013 Sep;43(9):2386-97. doi: 10.1002/eji.201243245. Epub 2013 Jul 15.

30.

Interferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosis.

Rocca S, Schiavoni G, Sali M, Anfossi AG, Abalsamo L, Palucci I, Mattei F, Sanchez M, Giagu A, Antuofermo E, Fadda G, Belardelli F, Delogu G, Gabriele L.

PLoS One. 2013 May 24;8(5):e62751. doi: 10.1371/journal.pone.0062751. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/cbf9ae84-2f74-4d4d-b2e7-b39e7ebaaaa8.

31.

The tumor microenvironment: a pitch for multiple players.

Schiavoni G, Gabriele L, Mattei F.

Front Oncol. 2013 Apr 17;3:90. doi: 10.3389/fonc.2013.00090. eCollection 2013.

32.

Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.

Gabriele L, Schiavoni G, Mattei F, Sanchez M, Sestili P, Butteroni C, Businaro R, Mirchandani A, Niedbala W, Liew FY, Afferni C.

J Allergy Clin Immunol. 2013 Sep;132(3):686-695.e7. doi: 10.1016/j.jaci.2013.02.037. Epub 2013 Apr 19.

PMID:
23608732
33.

Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents.

Burzotta F, Trani C, Talarico GP, Tommasino A, Todaro D, Coluccia V, Pirozzolo G, Niccoli G, Leone AM, Porto I, Schiavoni G, Crea F.

Cardiovasc Revasc Med. 2013 May-Jun;14(3):122-7. doi: 10.1016/j.carrev.2013.01.002. Epub 2013 Feb 27.

PMID:
23453789
34.

Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.

Tiacci E, Schiavoni G, Martelli MP, Boveri E, Pacini R, Tabarrini A, Zibellini S, Santi A, Pettirossi V, Fortini E, Ascani S, Arcaini L, Inghirami G, Paulli M, Falini B.

Haematologica. 2013 Apr;98(4):635-9. doi: 10.3324/haematol.2012.078071. Epub 2013 Jan 24.

35.

TIM-3 as a molecular switch for tumor escape from innate immunity.

Mattei F, Schiavoni G.

Front Immunol. 2013 Jan 9;3:418. doi: 10.3389/fimmu.2012.00418. eCollection 2012. No abstract available.

36.

IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

Mattei F, Schiavoni G, Sestili P, Spadaro F, Fragale A, Sistigu A, Lucarini V, Spada M, Sanchez M, Scala S, Battistini A, Belardelli F, Gabriele L.

Neoplasia. 2012 Dec;14(12):1223-35.

37.

Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?

Di Pietro M, Schiavoni G, Sessa V, Pallotta F, Costanzo G, Sessa R.

Osteoporos Int. 2013 May;24(5):1677-82. doi: 10.1007/s00198-012-2217-1. Epub 2012 Nov 16.

PMID:
23160916
38.

Management of the access site after transradial percutaneous procedures: literature overview.

Coluccia V, Burzotta F, Trani C, Brancati MF, Niccoli G, Leone AM, Schiavoni G, Crea F.

J Cardiovasc Med (Hagerstown). 2013 Oct;14(10):705-13. doi: 10.2459/JCM.0b013e3283577374. Review.

PMID:
23114269
39.

Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment.

Businaro L, De Ninno A, Schiavoni G, Lucarini V, Ciasca G, Gerardino A, Belardelli F, Gabriele L, Mattei F.

Lab Chip. 2013 Jan 21;13(2):229-39. doi: 10.1039/c2lc40887b. Epub 2012 Oct 30.

PMID:
23108434
40.

Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.

Coroleu SF, De Vita M, Burzotta F, Trani C, Porto I, Niccoli G, Leone AM, Tommasino A, Talarico GP, Schiavoni G, Crea F.

EuroIntervention. 2012 Oct;8(6):701-7. doi: 10.4244/EIJV8I6A109.

41.

Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial.

Venturelli E, Crisafulli E, DeBiase A, Righi D, Berrighi D, Cavicchioli PP, Vagheggini G, Dabrosca F, Balbi B, Paneroni M, Bianchi L, Vitacca M, Galimberti V, Zaurino M, Schiavoni G, Iattoni A, Ambrosino N, Clini EM.

Clin Rehabil. 2013 Apr;27(4):336-46. doi: 10.1177/0269215512458940. Epub 2012 Sep 11.

PMID:
22967853
42.

Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae.

Di Pietro M, Tramonti A, De Santis F, De Biase D, Schiavoni G, Filardo S, Zagaglia C, Sessa R.

J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2):277-84.

PMID:
22824742
43.

One-year outcomes of consecutive patients treated by Endeavor zotarolimus and Resolute zotarolimus stents: the impact of polymer coating in drug-eluting stent technology.

Talarico GP, Burzotta F, Trani C, Tommasino A, Niccoli G, Porto I, Leone AM, Mongiardo R, Schiavoni G, Crea F.

Catheter Cardiovasc Interv. 2013 Feb;81(2):268-73. doi: 10.1002/ccd.24498. Epub 2012 Nov 14.

PMID:
22639426
44.

Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures.

Burzotta F, Mariani L, Trani C, Coluccia V, Brancati MF, Porto I, Leone AM, Niccoli G, Tommasino A, Tinelli G, Mazzari MA, Mongiardo R, Snider F, Schiavoni G, Crea F.

Int J Cardiol. 2013 Sep 1;167(5):1973-8. doi: 10.1016/j.ijcard.2012.05.017. Epub 2012 May 26.

PMID:
22633677
45.

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.

Burzotta F, Brancati MF, Trani C, Porto I, Tommasino A, De Maria G, Niccoli G, Leone AM, Coluccia V, Schiavoni G, Crea F.

Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.

46.

EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions.

Coluccia V, Burzotta F, Romagnoli E, Trani C, Giammarinaro M, Talarico GP, Jannelli GV, Niccoli G, Porto I, Leone AM, Tommasino A, Schiavoni G, Crea F.

Int J Cardiol. 2013 Aug 20;167(4):1232-6. doi: 10.1016/j.ijcard.2012.03.149. Epub 2012 Apr 12.

PMID:
22503571
47.

Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study.

Trani C, Porto I, Tommasino A, Giammarinaro M, Burzotta F, Niccoli G, Leone AM, Coroleu SF, Cautilli G, Mazzari MA, Schiavoni G, Crea F.

Int J Cardiol. 2013 Aug 10;167(3):1006-11. doi: 10.1016/j.ijcard.2012.03.078. Epub 2012 Apr 13.

PMID:
22503569
48.

Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures.

Burzotta F, Trani C, Mazzari MA, Tommasino A, Niccoli G, Porto I, Leone AM, Tinelli G, Coluccia V, De Vita M, Brancati M, Mongiardo R, Schiavoni G, Crea F.

Am Heart J. 2012 Feb;163(2):230-8. doi: 10.1016/j.ahj.2011.10.019. Epub 2012 Jan 13.

PMID:
22305841
49.

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.

Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A, Cecchini D, Sozzi E, Francia di Celle P, Di Bello C, Pulsoni A, Foà R, Inghirami G, Falini B.

Blood. 2012 Jan 5;119(1):192-5. doi: 10.1182/blood-2011-08-371179. Epub 2011 Oct 25. Erratum in: Blood. 2013 Aug 29;122(9):1685.

50.

BRAF mutations in hairy-cell leukemia.

Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B.

N Engl J Med. 2011 Jun 16;364(24):2305-15. doi: 10.1056/NEJMoa1014209. Epub 2011 Jun 11.

Supplemental Content

Loading ...
Support Center